Dr. Kalyanaraman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
VA North Texas Health Care System - Dallas VA Medical Center
4500 S Lancaster Rd
Dallas, TX 75216- Is this information wrong?
Summary
- Board certified endocrinologist vast experience in thyroid disorders and biopsy bone densitometry obesity management adrenal disorders and pituitary disease. More than 9yrs experience in clinical and administration. Worked in executive position at VA. Primary Investigator of various grants from CDC, IHS, Metabolic care center Director, OKCIC.
Education & Training
- University of Oklahoma Health Sciences CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2006 - 2008
- Zucker School of Medicine at Hofstra/NorthwellFellowship, Pulmonary Disease and Critical Care Medicine, 1997 - 1998
- Zucker School of Medicine at Hofstra/Northwell at Forest Hills HospitalResidency, Internal Medicine, 1994 - 1997
- Kilpauk Medical CollegeClass of 1992
Certifications & Licensure
- IN State Medical License 1997 - 2025
- OK State Medical License 1997 - 2024
- MI State Medical License 2002 - 2006
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Diabetes disease state network AACE, 2020
- Bone and Parathyroid Disease State Network Diabetes Disease State Network Pituitary, Gonad, Adrenal and Neuroendocrine Disease State Network AACE
- AACE political liaison AACE
Publications & Presentations
PubMed
- 15 citationsReduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetesYongxin Jeremy Yu, Kristian F. Hanssen, V. Kalyanaraman, A. Chirindel, Alicia J. Jenkins, Alison Nankervis, Peter A. Torjesen, Hanne Scholz, Tore Henriksen, Bjørg Lore...> ;BJOG. 2012 Nov 1
- Difficulties in monitoring the glucose status of patients undergoing hematopoietic stem cell transplantation.George B. Selby, Melody Mosallaei-Benjamin, Venkataraman Kalyanaraman, Andrew Lancaster, R. H. Scofield> ;Biology of Blood and Marrow Transplantation. 2009 Aug 1
Grant Support
- GWICCDC2019–2024
- SDPICDC2018–Present
- AstraZeneca cardiovascular outcomesAstraZeneca2020–2021
Committees
- Board Member, Interfaith alliance 2015 - Present
Research History
- Reduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetesReduced soluble receptor for advanced glycation end-products (sRAGE) scavenger capacity precedes pre-eclampsia in Type 1 diabetes PMID: 22900949 PMCID: PMC3980671 DOI: 10.1111/j.1471-0528.2012.03463.x2006 - 2009
- ResearcherGlucose status of patients undergoing hematopoietic stem cell transplantation PMID: 19589491 DOI: 10.1016/j.bbmt.2009.05.0022007 - 2008
Professional Memberships
- Member
- Member
Other Languages
- Tamil
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: